Patents by Inventor Alan Faull

Alan Faull has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • (4-TERT-BUTYLPIPERAZIN-2-YL)(PIPERAZIN-1-YL)METHANONE-N-CARBOXAMIDE DERIVATIVES
    Publication number: 20130289043
    Abstract: The present invention relates to compounds of formula (I) The compounds act via antagonism of the CCR2b receptor and may be used to treat inflammatory disease and/or neuropathic pain.
    Type: Application
    Filed: June 27, 2013
    Publication date: October 31, 2013
    Applicant: AstraZeneca AB
    Inventors: John Cumming, Alan Faull, David Waterson
  • Novel Compounds
    Publication number: 20110152234
    Abstract: The invention relates to thiophene carboxamides of formula (I), wherein A, R1, R2, R3, n and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: December 23, 2010
    Publication date: June 23, 2011
    Inventors: Alan Faull, Craig Johnstone, Andrew Morley, Jeffrey Philip Poyser
  • Phenyl thiophene carboxamide compounds as inhibitors of the enzyme IKK-2
    Patent number: 7956084
    Abstract: The invention relates to thiophene carboxamides of formula (I), wherein A, R1, R2, R3, n and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: September 6, 2006
    Date of Patent: June 7, 2011
    Assignee: AstraZeneca AB
    Inventors: Alan Faull, Craig Johnstone, Andrew Morley, Jeffrey Philip Poyser
  • PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR CCR5
    Publication number: 20100010007
    Abstract: Compounds of formula (I): compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).
    Type: Application
    Filed: September 18, 2009
    Publication date: January 14, 2010
    Applicant: AstraZeneca AB
    Inventors: Alan Faull, Howard Tucker
  • Piperidine derivatives as modulators of chemokine receptor CCR5
    Patent number: 7615555
    Abstract: Compounds of formula (I): compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).
    Type: Grant
    Filed: April 20, 2005
    Date of Patent: November 10, 2009
    Assignee: AstraZeneca AB
    Inventors: Alan Faull, Howard Tucker
  • Substituted thiophene compounds
    Publication number: 20090181962
    Abstract: The invention relates to heteroaromatic carboxamides of formula (I), wherein A, R1, R2, and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: December 3, 2007
    Publication date: July 16, 2009
    Inventors: Andrew Baxter, Stephen Brough, Alan Faull, Craig Johnstone, Thomas Mcinally
  • Substituted Thiophene compounds
    Patent number: 7358376
    Abstract: The invention relates to heteroaromatic carboxamides of formula (I), wherein A, R1, R2 and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: February 7, 2001
    Date of Patent: April 15, 2008
    Assignee: AstraZeneca AB
    Inventors: Andrew Baxter, Stephen Brough, Alan Faull, Craig Johnstone, Thomas McInally
  • Novel Piperidine/8-Azabicyclo [3.2.1.] Octan Derivatives As Modulators Of Chemokine Receptor Ccr5
    Publication number: 20080021038
    Abstract: Compounds of formula (I) wherein neither R4 nor R5 is hydrogen; compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).
    Type: Application
    Filed: June 20, 2005
    Publication date: January 24, 2008
    Inventors: Howard Tucker, Alan Faull
  • Chemical compounds
    Patent number: 7294636
    Abstract: Compounds of formula (I): compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal)
    Type: Grant
    Filed: May 6, 2004
    Date of Patent: November 13, 2007
    Assignee: AstraZeneca AB
    Inventors: John Cumming, Alan Faull
  • Thienopyrimidines and Thiazolopyrimidines for Use in Medicine
    Publication number: 20070244133
    Abstract: The use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein X1, X2, X3, X4, Ra, p, R1, Z, Y, R2, R3 and R4 are as defined in the specification, in the preparation of a medicament for the treatment of C—C chemokine mediated conditions, such as inflammatory disease. Certain compounds of formula (I) are novel and these, together with their preparation are also described and claimed.
    Type: Application
    Filed: May 31, 2005
    Publication date: October 18, 2007
    Inventors: Justin Bower, Alan Faull, Jon Winter
  • Chemical compounds
    Publication number: 20070167442
    Abstract: Compounds of formula (I): compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).
    Type: Application
    Filed: April 20, 2005
    Publication date: July 19, 2007
    Inventors: Alan Faull, Howard Tucker
  • Novel compounds
    Publication number: 20070015819
    Abstract: The invention relates to thiophene carboxamides of formula (I), wherein A, R1, R2, R3, n and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: September 6, 2006
    Publication date: January 18, 2007
    Inventors: Alan Faull, Craig Johnstone, Andrew Morley, Jeffrey Poyser
  • Chemical compounds
    Publication number: 20070015788
    Abstract: Compounds of formula (I): compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).
    Type: Application
    Filed: May 6, 2004
    Publication date: January 18, 2007
    Inventors: John Cumming, Alan Faull
  • Thiophene carboxamide compounds as inhibitors of enzyme IKK-2
    Patent number: 7125896
    Abstract: The invention relates to thiophene carboxanmides of formula (I), wherein A, R1, R2, R3, n and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: October 24, 2006
    Assignee: AstraZeneca AB
    Inventors: Alan Faull, Craig Johnstone, Andrew Morley, Philip Jeffrey Poyser
  • Novel piperidine derivatives as modulators of chemokine receptor ccr5
    Publication number: 20060189650
    Abstract: Compounds of formula (I) wherein R1, R2R3, R4, ?, X, m and n are as defined; compositions comprising them, processes for preparing them and their use in medical therapy them and their use in medical therapy (for example mod ulating CCR5 receptor activity in a warm blooded animal).
    Type: Application
    Filed: December 18, 2003
    Publication date: August 24, 2006
    Inventors: John Cumming, Alan Faull, Colin Fielding, John Oldfield, Howard Tucker
  • Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
    Publication number: 20060058522
    Abstract: The invention relates to thiophene carboxamides of formula (I), wherein A, R1, R2, R3, R4, R5 and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: January 13, 2004
    Publication date: March 16, 2006
    Inventors: Alan Faull, Craig Johnstone, Andrew Morley, Jeffrey Poyser
  • Novel compounds
    Publication number: 20040242573
    Abstract: The invention relates to thiophene carboxanmides of formula (I). wherein A, R1, R2, R3, n and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: January 22, 2004
    Publication date: December 2, 2004
    Inventors: Alan Faull, Craig Johnstone, Andrew Morley, Jeffrey Philip Poyser
  • Novel Compounds
    Publication number: 20020107252
    Abstract: The invention relates to heteroaromatic carboxamides of formula (I), 1
    Type: Application
    Filed: February 5, 2002
    Publication date: August 8, 2002
    Inventors: Andrew Baxter, Stephen Brough, Alan Faull, Craig Johnstone, Thomas McInally